CanFel Therapeutics is an emerging veterinary oncology company with the mission of improving the treatment of cats and dogs afflicted with cancer. Our goal is to improve cancer care for companion animals by developing a new class of cancer-fighting drugs. Antibody therapeutics are the most successful class of drugs over the last 20 years to be used to treat cancer in humans. However, these therapies have not been made available for treating cancer in animals.

CanFel's founding team has extensive experience discovering and developing antibody drugs for use in humans and is applying this expertise to develop new antibody drugs for companion animals. Using advanced cell-based discovery techniques, we are developing canine and feline versions of antibody therapeutics widely used to treat cancer in humans.